← FDA Drug Approvals (Drugs@FDA)
BEPOTASTINE BESILATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2019-03-05
Drug application
- FDA Application #
ANDA206066- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BEPOTASTINE BESILATE
- Generic name
- Bepotastine Besilate
- Active ingredients
- BEPOTASTINE BESILATE
- Dosage form
- SOLUTION/DROPS
- Route
- OPHTHALMIC
- Marketing status
- Discontinued
- Sponsor
- APOTEX
- First approval
- 2019-03-05
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown